Showing 1 - 10 of 13
We estimate the current impact of Medicare on medical expenditure risk and financial strain. At age 65, out-of-pocket expenditures drop by 33% at the mean and 53% among the top 5% of spenders. The fraction of the population with out- of-pocket medical expenditures above income drops by more than...
Persistent link: https://www.econbiz.de/10013057414
We estimate the current impact of Medicare on medical expenditure risk and financial strain. At age 65, out-of-pocket expenditures drop by 33% at the mean and 53% among the top 5% of spenders. The fraction of the population with out-of-pocket medical expenditures above income drops by more than...
Persistent link: https://www.econbiz.de/10013058039
Persistent link: https://www.econbiz.de/10014303402
Persistent link: https://www.econbiz.de/10010530882
Persistent link: https://www.econbiz.de/10011393063
Persistent link: https://www.econbiz.de/10011588864
Generic drugs comprise an increasing share of total prescriptions dispensed in the U.S., rising from nearly 50 percent in 1999 to 75 percent in 2009. The generic drug market has typically been viewed at the wholesale level as a competitive market with price approaching marginal costs. However,...
Persistent link: https://www.econbiz.de/10012459294
Persistent link: https://www.econbiz.de/10014288035
This paper quantifies the anticipatory effects of the passage of Medicare Part D on prescription drug utilization. Part D expanded Medicare to include insurance coverage for prescription drugs for the first time. While the program was implemented in 2006, it had been signed into law two years...
Persistent link: https://www.econbiz.de/10014164755
Generic drugs comprise an increasing share of total prescriptions dispensed in the U.S., rising from nearly 50 percent in 1999 to 75 percent in 2009. The generic drug market has typically been viewed at the wholesale level as a competitive market with price approaching marginal costs. However,...
Persistent link: https://www.econbiz.de/10013076920